IRTC - iRhythm Technologies, Inc.
| Previous Close | 72.61 |
| Open | 73.15 |
| Bid | 73.08 x 900 |
| Ask | 99.90 x 900 |
| Day's Range | 72.07 - 74.50 |
| 52 Week Range | 58.99 - 98.37 |
| Volume | 270,482 |
| Avg. Volume | 303,811 |
| Market Cap | 1.817B |
| Beta (3Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.82 |
| Earnings Date | Oct 28, 2019 - Nov 1, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 101.63 |
- Simply Wall St.
Did Changing Sentiment Drive iRhythm Technologies's (NASDAQ:IRTC) Share Price Down By 12%?
It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do...
- Zacks
IRHYTHM TECH (IRTC) Reports Q2 Loss, Tops Revenue Estimates
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -2.22% and 6.89%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
iRhythm Technologies Announces Second Quarter 2019 Financial Results
SAN FRANCISCO, July 31, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
- GlobeNewswire
iRhythm Technologies to Present at the 39th Annual Canaccord Genuity Global Growth Conference
SAN FRANCISCO, July 24, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
- Zacks
IRHYTHM TECH (IRTC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
iRhythm Technologies to Report Second Quarter Financial Results on July 31, 2019
SAN FRANCISCO, July 17, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today.
- Simply Wall St.
One Thing To Remember About The iRhythm Technologies, Inc. (NASDAQ:IRTC) Share Price
If you're interested in iRhythm Technologies, Inc. (NASDAQ:IRTC), then you might want to consider its beta (a measure...
- GlobeNewswire
iRhythm Technologies to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
SAN FRANCISCO, June 05, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
- GlobeNewswire
iRhythm Technologies Announces Investor Update Webcast on May 9, 2019
SAN FRANCISCO, May 08, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health company focused on the advancement of cardiac care, announced today that it.
Motley FooliRhythm Technologies, Inc. Common Stock (IRTC) Q1 2019 Earnings Call Transcript
IRTC earnings call for the period ending March 31, 2019.
- Zacks
IRHYTHM TECH (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 34.00% and 8.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
iRhythm Technologies Announces First Quarter 2019 Financial Results
SAN FRANCISCO, May 07, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today.
- ACCESSWIRE
iRhythm Technologies, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 7, 2019 / iRhythm Technologies, Inc. (NASDAQ: IRTC ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 4:30 PM ...
- Insider Monkey
Hedge Funds Have Never Been More Bullish On iRhythm Technologies, Inc. (IRTC)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
- GlobeNewswire
IRTC INVESTIGATION REMINDER: Hagens Berman Reminds iRhythm Technologies (IRTC) Investors of the Firm’s Ongoing Investigation, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm
Hagens Berman Sobol Shapiro LLP, with 9 offices in 8 cities around the country and 80 attorneys, reminds investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) of the firm’s ongoing investigation of possible securities law violations.
- Zacks
Analysts Estimate IRHYTHM TECH (IRTC) to Report a Decline in Earnings: What to Look Out for
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
iRhythm Technologies to Report First Quarter Financial Results on May 7, 2019
SAN FRANCISCO, April 23, 2019 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today.
- Business Wire
Glancy Prongay & Murray LLP Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors (IRTC)
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company and its officers’ possible violations of federal securities laws. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. Between March 13 and March 27, 2019, a series of reports alleged that the Company’s revenue base relied on “an exceedingly generous, but increasingly fragile, reimbursement regime.” These reports also alleged that the Company engaged in deceptive accounting practices.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC)
NEW YORK, NY / ACCESSWIRE / April 10, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc.("iRhythm" or the "Company") ...
- Business Wire
Robbins Arroyo LLP Is Investigating the Officers and Directors of iRhythm Technologies, Inc. (IRTC) on Behalf of Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of iRhythm Technologies, Inc. breached their fiduciary duties to shareholders by failing to maintain effective internal controls over financial reporting.
- Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of iRhythm Technologies, Inc. Investors
Law Offices of Howard G. Smith announces an investigation on behalf of iRhythm Technologies, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
- Business Wire
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
